Opinion

Video

CGM: Redefining Type 2 Diabetes Management

Author(s):

Davida Kruger, MSN, APN-BC, BC-ADM

A panelist discusses how continuous glucose monitoring (CGM) technology can help overcome therapeutic inertia and key barriers to glycemic control in type 2 diabetes (T2D) patients by providing real-time data that enables earlier interventions, supports treatment optimization, and helps managed care organizations justify broader CGM adoption for newly diagnosed patients.

Video content above is prompted by the following:

  • What are the primary barriers to achieving early and consistent glycemic control in T2D patients?
  • How can CGM technology help clinicians address therapeutic inertia in diabetes care?
  • What role does CGM play in reducing the time patients spend with suboptimal glucose management?
  • How can managed care organizations support earlier adoption of CGM in newly diagnosed T2D patients?
Related Videos
Dr Emma Achola-Kothani
Marla Black Morgan, MD, Phoebe Neurology Associates
Christine Funke, MD
5 experts are featured in this series
5 experts are featured in this series
Nini Wu, MD, Navista
Dr Emma Achola-Kothari
1 expert in this video
1 expert in this video
Related Content
AJMC Q&A with Eileen Peng, PharmD | Background image credit: ipopba - stock.adobe.com
May 21st 2025

The Role of Pharmacists Expands Beyond Dispensing for Novel Cancer Therapies: Eileen Peng, PharmD

Laura Joszt, MA Eileen Peng, PharmD
The advent of novel cancer care therapies such as chimeric antigen receptor T-cell therapy and bispecific antibodies is transforming the role of pharmacists in enhancing patient care.
Managed Care Cast
May 20th 2025

Mental Health Awareness: Transforming Workplace Support and Engagement

Giuliana Grossi Jim Kinville
Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Pill bottle with money inside | Image credit: Kenishirotie - stock.adobe.com
May 20th 2025

HHS Sets Pricing Target for Trump’s Most Favored Nation Drug Price Model

Laura Joszt, MA
Following President Donald Trump's most favored nation executive order, HHS and CMS have released the target price for pharmaceutical manufacturers to meet.
managed care cast logo
May 13th 2025

Inside the Center's MDD Value Model and Its Use of Dynamic Pricing

Brooke McCormick Larragem Raines, MS
Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
FDA | Image credit: Postmodern Studio
May 20th 2025

Is the US Headed for an Infectious Disease Pandemic?

Giuliana Grossi
In an era that FDA Commissioner Marty Makary, MD, MPH, calls an "epidemic of distrust" toward health institutions, previously contained disease rates are rapidly rising, and vaccination rates are proceeding in the opposite direction.
Center on Health Equity and Access
May 19th 2025

Health Equity & Access Weekly Roundup: May 19, 2025

Giuliana Grossi
Proposed Medicaid cuts risk increasing health disparities, leaving millions uninsured and limiting access to essential care for vulnerable populations.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo